PATENT CLAIM ANALYSIS

Application Number: 16161198
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "210000"]

Abstract:
The present invention is related to amino thiazole derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).

Claim (Index 20):
The method according to  claim 1 , wherein the skin disease or disorder is selected from psoriasis, eczema, scleroderma, xeroderma pigmentosum, skin cancers, melanoma, erythropoietic protoporphyria, discoid lupus erythematosus, solar urticaria, polymorphous light eruption, dermatitis, wound healing and scar formation.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.16216
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15536800', '13120436', '13755387', '14750019', '13120440']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7573803794836884
- 35 USC 102 Novelty (BERT): 0.5885519074385125
- Combined Prediction Score: 0.7404975322791708
- Mean Citation Score: 405.248922
- Max Citation Score: 603.7789
- Similarity Product: 366.3213336446405

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test